Add to my selection

VIPDOMET (alogliptine/metformine), antidiabétiques

Medicine - Posted on Feb 17 2023

Active substance (DCI)

alogliptine (benzoate d')
metformine (chlorhydrate de)

history (3)

7/21/21

VIPIDIA - VIPDOMET (alogliptine / metformine)

Key points The Committee reassessed 12 proprietary medicinal products containing 5 different gliptin substances, including 6...

CAV :
54321

icône flèche
7/21/21

VIPIDIA - VIPDOMET (alogliptine / metformine)

Key points The Committee reassessed 12 proprietary medicinal products containing 5 different gliptin substances, including 6...

CAV :
54321

icône flèche
10/1/14

VIPIDIA (alogliptin) and VIPDOMET (alogliptin/metformin), antidiabetics

No clinical benefit demonstrated in the management of patients with type 2 diabetes VIPIDIA has Marketing Authorisation in t...

CAV :
54321

icône flèche

Technical information

ATC code

A10BD13

Manufacturer

TAKEDA

Presentation

VIPDOMET 12,5 mg/1000 mg, comprimé pelliculé (code CIS : 66037572)
plaquette(s) thermoformée(s) polychlortrifluoroéthylène PVC-Aluminium de 56 comprimé(s) (CIP : 34009 276 967 3 2)

All our publications

Diabetes mellitus

Drug therapy

My account

You do not have a saved search

VIPDOMET (alogliptine/metformine), antidiabétiques

VIPIDIA - VIPDOMET (alogliptine / metformine)

VIPIDIA - VIPDOMET (alogliptine / metformine)

VIPIDIA (alogliptin) and VIPDOMET (alogliptin/metformin), antidiabetics

Follow us :